CDE Catalog | NINDS Common Data Elements

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Subdomain Name

CRF Name

Displaying 51 - 75 of 755

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

Operations

Selected 25 rows in this page.

The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
Select all	CDE ID	CDE Name	Definition	Classification	CRF Name	Copyrighted or trademarked	Disease Name	Subdisease Name
F0022-C02004	C02004	Study drug dispensed date and time	Date (and time, if applicable and known) on which a participant/subject was given or applied a therapeutic agent (drug, intervention therapy) used in a clinical trial protocol	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)
F0022-C02018	C02018	Study drug dispensed count	Count of amount of study drug dispensed to the participant/subject	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)
F0022-C02019	C02019	Study drug actual return count	Count of amount of study drug returned	Supplemental	Study Drug Compliance	False	General (For all diseases)	General (For all diseases)
F0004-C20402	C20402	Study blind broken indicator	Indicator of whether the study blind was broken	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0025-C01700	C01700	Specimen accession number	Number with which the specimen taken for the tests being reported was accessioned to the record storage facility	Supplemental	Laboratory Tests and Tracking	False	General (For all diseases)	General (For all diseases)
F0003-C18751	C18751	Sex participant or subject genotype other text	The free-text field related to 'Sex participant or subject genotype type' specifying other text. The difference between male and female, based upon the interactions between genes and between the genotype and the environment. Genotype is identified based on the individual's reproductive organs and functions assigned by chromosomal complement	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0003-C17396	C17396	Sex genotype type	The difference between male and female, based upon the interactions between genes and between the genotype and the environment. Genotype is identified based on the individual's reproductive organs and functions assigned by chromosomal complement	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0004-C20392	C20392	Serious adverse event treatment description text	The free-text field that describes the interventions specific to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60372	C60372	Serious adverse event threaten life indicator	Indicator of whether the serious adverse event is life threatening	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20398	C20398	Serious adverse event study intervention administration text	The free-text field to describe the administration of study intervention	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20393	C20393	Serious adverse event start date and time	Date (and time, if applicable and known) on which the serious adverse event was first evident	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60385	C60385	Serious adverse event sponsor assessment indicator	Indicator of whether the adverse event is serious, based on the sponsor's assessment	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60369	C60369	Serious adverse event site aware date and time	Date (and time, if applicable and known) on which the site first became aware of the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60375	C60375	Serious adverse event result persistent significant disability incapacity indicator	Indicator of whether the serious adverse event resulted in persistent or significant disability or incapacity	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60371	C60371	Serious adverse event result death indicator	Indicator of whether the serious adverse event resulted in death	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20400	C20400	Serious adverse event resolve end study intervention indicator	Indicator of whether a serious adverse event ended after the study intervention was stopped	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20408	C20408	Serious adverse event report type	Type of report being completed for the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20415	C20415	Serious adverse event report complete date	Date when the report on the serious adverse event was completed	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20397	C20397	Serious adverse event relevant history text	The free-text field that describes relevant history including pre-existing medical conditions specific to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20401	C20401	Serious adverse event reappearance restart study intervention indicator	Indicator of whether the adverse event reappeared after the study intervention was restarted	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60378	C60378	Serious adverse event other important medical event text	The free-text field to describe the medically important event not covered by other 'serious' criteria	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60377	C60377	Serious adverse event other important medical event indicator	Indicator of whether the serious adverse event is a medically important event not covered by other 'serious' criteria	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60370	C60370	Serious adverse event ongoing indicator	Indicator of whether the serious adverse event experienced by the participant is ongoing	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20395	C20395	Serious adverse event laboratory data text	The free-text field that describes the relevant tests or laboratory data specific to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60381	C60381	Serious adverse event investigator assessment reason other text	The free-text field related to 'Serious adverse event investigator assessment reason', specifying other text. Reason in the opinion of the principal investigator that is attributed as the cause of the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)

Displaying 51 - 75 of 755

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.